Issue Information

LiverRCT IIT : Promoting Investigator‐Initiated Randomized Controlled Trials for the Key Clinical Issues in Liver Disease Prevention and Treatment
von: Xiaolong Qi, et al.
Veröffentlicht: (2025)

Effects of Shunt Position on the Prognosis of Transjugular Intrahepatic Portosystemic Shunt in Patients With Cirrhotic Esophagogastric Variceal Bleeding
von: Yi‐Han Yang, et al.
Veröffentlicht: (2025)

Liver Cirrhosis and Sleep Disorders
von: Jiawen Feng, et al.
Veröffentlicht: (2025)

Endoscopic Submucosal Dissection for Early Esophageal Squamous Cell Carcinoma Located at Esophageal Varices Caused by Liver Cirrhosis
von: Wenlan Zheng, et al.
Veröffentlicht: (2025)

Deep Learning‐Based Prediction of High‐Risk Gastroesophageal Varices Using Two‐Dimensional Shear Wave Elastography
von: Lan Wang, et al.
Veröffentlicht: (2025)

Successful Embolization for Recurrent Encephalopathy Caused by Type II Abernethy Malformation
von: Hongliang Wang, et al.
Veröffentlicht: (2025)

Portal Hypertension—Noninvasive Multiparametric Ultrasound‐Based Criteria and Measurements
von: Kathleen Möller, et al.
Veröffentlicht: (2025)

Radiomic Analysis of Contrast‐Enhanced CT Predicts Recompensation in Hepatitis B‐Related Decompensated Cirrhosis
von: Qiaofeng Chen, et al.
Veröffentlicht: (2025)

Commentary on “Portal Hypertension‐Noninvasive Multiparametric Ultrasound Based Criteria and Measurements”
von: Yi Dong
Veröffentlicht: (2025)

Pharmacotherapy for Cirrhosis in Japan
von: Hiroki Nishikawa, et al.
Veröffentlicht: (2025)

The Prognostic Significance of Handgrip Strength in Cirrhosis: Simplicity Is the Ultimate Sophistication
von: Binxin Cui, et al.
Veröffentlicht: (2025)

Artificial Liver Therapy Ameliorates Hepatitis B Virus–Related Acute‐on‐Chronic Liver Failure by Remodeling the Microbiota Structure
von: Wei Huang, et al.
Veröffentlicht: (2025)

Serum Creatinine of 1.1 mg/dL Can Indicate Disease Deterioration and 90‐day Mortality in Hospitalized Patients With Cirrhosis in Chinese Population
von: Lindan Xie, et al.
Veröffentlicht: (2025)

Predictive Value of Coagulation Factor VIII and Protein C Levels for Further Decompensated Events in Patients With Decompensated Cirrhosis
von: Siyu Jiang, et al.
Veröffentlicht: (2025)

Research Progress of Noninvasive Evaluation of Portal Hypertension by Blood‐Based Tests
von: Wei Chen, et al.
Veröffentlicht: (2025)

Epidemiological Characteristics of Acute‐on‐Chronic Liver Failure in Patients With Compensated Liver Disease: A Systematic Review and Meta‐Analysis
von: Lei Liu, et al.
Veröffentlicht: (2025)

Resmetirom and Thyroid Hormone Receptor‐Targeted Treatment for Metabolic Dysfunction‐Associated Steatotic Liver Disease (MASLD)
von: Chang‐Hai Liu, et al.
Veröffentlicht: (2025)

Advances in Factors and Risk Prediction of Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt
von: Lixin Song, et al.
Veröffentlicht: (2025)

Transjugular Intrahepatic Portosystemic Shunt (TIPS) Promotes Wound Healing in Cirrhotic Patients With Post‐Splenectomy Complications
von: Na Han, et al.
Veröffentlicht: (2025)

The Interplay Between Alcohol Consumption and Cardiometabolic Risk Factors in Individuals With MASLD and MetALD
von: Yee Hui Yeo, et al.
Veröffentlicht: (2025)

Postoperative TIPS Reaction in a Patient With Portal Vein Dysfunction
von: Qihao Du, et al.
Veröffentlicht: (2025)

The Role of Magnesium in Liver Cirrhosis
von: Weiye Zeng, et al.
Veröffentlicht: (2025)

Correction to “Multifrequency Multiparameter Magnetic Resonance Elastography Applied to an In Vivo Porcine Model for Assessing Portal Hypertension”
Veröffentlicht: (2026)

Author Guidelines
Veröffentlicht: (2024)

One‐year status of hepatic venous pressure gradient measurement from 85 hospitals in China
von: Jitao Wang, et al.
Veröffentlicht: (2024)

Dawn of an era of effective treatments for MAFLD
von: Cameron Gofton, et al.
Veröffentlicht: (2024)

Massive Lower Gastrointestinal Bleeding Due to Colonic Telangiectasia
von: Xuan Ren, et al.
Veröffentlicht: (2024)

Molecular mechanisms of hepatic lipid metabolism disorders: Focus on mitochondrial quality control
von: Jiachi Yu, et al.
Veröffentlicht: (2024)

Endovascular embolization for upper gastrointestinal bleeding due to portal hypertension caused by a superior mesenteric arteriovenous fistula
von: Yu He, et al.
Veröffentlicht: (2024)

Serum markers for detecting histological features of autoimmune hepatitis and predicting prognosis in patients with antinuclear antibody‐positive drug‐induced liver injury
von: Feiyu Zhang, et al.
Veröffentlicht: (2024)

Correction to “Chinese Expert Consensus on the Use of Ultrasound‐Derived Fat Fraction in the Assessment of Metabolic Dysfunction‐Associated Steatotic Liver Disease (2025 Edition)”
Veröffentlicht: (2026)

Application of subharmonic‐aided pressure estimation in a patient with giant hepatic cyst: A case report
von: Xiuyun Lu, et al.
Veröffentlicht: (2024)

Correction to “Factors Associated With Liver Fibrosis in Patients With Type 2 Diabetes and the Predictive Value of CHI3L1”
Veröffentlicht: (2026)

Endoscopic ultrasound‐guided portal pressure gradient identifies patients with previously undiagnosed clinically significant portal hypertension
von: Jerome C. Edelson, et al.
Veröffentlicht: (2024)

When Fat Goes Astray: Your Liver and Pancreas Get Into Trouble
von: Yuying Chen, et al.
Veröffentlicht: (2026)

Current Cell/Organoid and Animal Models for Primary Sclerosing Cholangitis
von: Qigu Yao, et al.
Veröffentlicht: (2026)